US2004161830A1PendingUtilityA1
Spherical microparticles containing linear polysaccharides
Priority: Aug 28, 1997Filed: Feb 6, 2004Published: Aug 19, 2004
Est. expiryAug 28, 2017(expired)· nominal 20-yr term from priority
C08J 2305/00C08J 3/14A61K 9/1652
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Microparticles with a uniform spherical shape and a very narrow size distribution are described. They consist wholly or partly of a linear water-insoluble polysaccharide, preferably of 1,4-α-D-polyglucan, and may contain other, in particular biodegradable, polymers and/or active substances. They are suitable inter alia for the controlled delivery of active substances. They are prepared by dissolving 1,4-α-D-polyglucan or the polysaccharide in a solvent, introducing the solution into a precipitant, cooling the mixture and removing the particles formed.
Claims
exact text as granted — not AI-modified1 . Spherical microparticles having an average diameter of 1 nm to 100 μm, consisting wholly or partly of at least one water-insoluble linear polysaccharide.
2 . Spherical microparticles having an average diameter of 1 nm to 100 μm, consisting wholly or partly of at least one water-insoluble linear polysaccharide which has been prepared in a biotechnological process.
3 . Spherical microparticles having an average diameter of 1 nm to 100 μm as claimed in claim 2 , consisting wholly or partly of at least one water-insoluble linear polysaccharide which has been prepared by a biocatalytic process.
4 . Spherical microparticles having an average diameter of 1 nm to 100 μm as claimed in claim 2 , consisting wholly or partly of at least one water-insoluble linear polysaccharide which has been prepared by a fermentation process.
5 . Spherical microparticles as claimed in claim 1 , consisting wholly or partly of 1,4-α-D-polyglucan.
6 . Microparticles as claimed in claim 5 , wherein 1,4-α-D-polyglucan has been prepared by a biocatalytic process using polysaccharide synthases.
7 . Microparticles as claimed in, claim 5 , wherein 1,4-α-D-polyglucan has been prepared by a biocatalytic process using starch synthases.
8 . Microparticles as claimed in claim 5 , wherein 1,4-α-D-polyglucan has been prepared by a biocatalytic process using glycosyl-transferases.
9 . Microparticles as claimed in claim 5 , wherein 1,4-α-D-polyglucan has been prepared by a biocatalytic process using α-1,4-glucan transferases.
10 . Microparticles as claimed in claim 5 , wherein 1,4-α-D-polyglucan has been prepared by a biocatalytic process using glycogen synthases.
11 . Microparticles as claimed in claim 5 , wherein 1,4-α-D-polyglucan has been prepared by a biocatalytic process using amylosucrases.
12 . Microparticles as claimed in claim 5 , wherein 1,4-α-D-polyglucan has been prepared by a biocatalytic process using phosphorylases.
13 . Microparticles as claimed in claim 1 , wherein the linear polysaccharides have been prepared by enzymatic treatment of branched or highly branched polysaccharides.
14 . Microparticles as claimed in at least one of claims 1 to 13 having an average diameter of 100 nm to 10 μm, preferably 1 to 3 μm.
15 . Microparticles as claimed in at least one of claims 1 to 14 , having a narrow distribution of particle diameters (dispersity).
16 . Microparticles as claimed in claim 15 , wherein the dispersity of the particle diameters d w to d n is 1.0 to 10.0, preferably 1.5 to 5.0, in particular 2.0 to 2.6.
17 . Microparticles as claimed in at least one of claims 1 to 16 , which additionally comprise one or more, preferably biodegradable polymers.
18 . Microparticles as claimed in one or more of claims 1 to 17 , which additionally comprise one or more active substances.
19 . A process for preparing spherical microparticles which consist wholly or partly of water-insoluble linear polysaccarides, in particular 1,4-α-D-polyglucan, by dissolving the water-insoluble linear polysaccharide or the 1,4-α-D-polyglucan in a solvent, introducing the solution into a precipitant, cooling the mixture resulting therefrom, and removing the microparticles formed.
20 . The process as claimed in claim 19 , wherein solution and precipitant are mixed at temperatures from 20 to 50° C., and the mixture is cooled to temperatures from +10 to −10° C., preferably 5 to −5° C.
21 . The process as claimed in claim 19 or 20 , wherein dimethyl sulfoxide is used as solvent.
22 . The process as claimed in at least one of claims 19 to 21 , wherein water or an aqueous medium is used as precipitant.
23 . The process as claimed in at least one of claims 19 to 22 , wherein the solution is prepared in the presence of one or more polymers, in particular biodegradable polymers, and/or of one or more active substances.
24 . The use of the microparticles as claimed in at least one of claims 1 to 18 or of the microparticles prepared by a process as claimed in at least one of claims 19 to 23 for the controlled delivery of active substances.
25 . The use of the microparticles as claimed in at least one of claims 1 to 18 or of the microparticles, prepared by a process as claimed in at least one of claims 19 to 23 as standard for determining the size of particles.Join the waitlist — get patent alerts
Track US2004161830A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.